Pre-Clinical Characterization and Process Development of a Bcma-Directed Car Nk-Cell Therapy Product for Relapsed/Refractory Multiple Myeloma

Name: Pre-Clinical Characterization and Process Development of a Bcma-Directed Car Nk-Cell Therapy Product for Relapsed/Refractory Multiple Myeloma
Start: 2026-11-18T12:00
End: 2026-11-18T12:45
Location: Palais des congrès de Montréal

2026 ASCP/CAP-ACP Annual Meeting · 18 November 2026 · 12:00–12:45 · 517ABC - Exhibit Hall

Pre-Clinical Characterization and Process Development of a Bcma-Directed Car Nk-Cell Therapy Product for Relapsed/Refractory Multiple Myeloma was a session at 2026 ASCP/CAP-ACP Annual Meeting on 18 November 2026 in Montreal, with 1 speaker on record.

Speakers

Charles Yin — Speaker Lymphoproliferative Disorders and Cellular Therapy Fellow, Kyndryl